Aktana

Canaccord Genuity Advises Aktana on its Sale to PharmaForceIQ

Acquisition will deliver the industry’s first optichannel-in-a-box solution for pharma companies – an end-to-end commercial customer engagement system that can go live in as little as 6–8 weeks

Canaccord Genuity has advised Aktana, a leader in intelligent customer engagement for life sciences, on its sale to PharmaForceIQ, a leading end-to-end healthcare professional (HCP) and patient omnichannel solution provider for pharmaceutical marketing, medical, and clinical teams and an Eir Partners portfolio company. The acquisition aligns Aktana’s advanced Next-Best-Action (NBA) platform with the industry's premier marketing orchestration platform. 

The strategic move creates the most holistic solution available to unify brand and field strategy, drive executional alignment, and measure impact immediately. The integration of PharmaForceIQ’s modular, ML-powered agile platform and Aktana’s sophisticated AI core will enable long-term scalability and innovation across the entire combined platform.

Applying optichannel engagement strategies across both field and digital drives massive efficiency gains across the commercial function:

• 3x average script lift
• A 22% increase in brand strategy adherence
• An 80% increase in HCP engagement rates
• 20-30% budget savings over traditional media buying models

The asset acquisition deepens PharmaForceIQ’s footprint significantly in the United States, as well as bringing the platform to even more markets in the LATAM, APAC, and EMEA regions. The platform will also expand its capabilities in field engagement, offering even deeper predictive insights to help field teams improve their work.

The field NBA platform is powered by Aktana’s proprietary Knowledge Nexus dataset – real-world insights on 85+ validated use cases drawn from more than 100 million field suggestions made and 5,000+ tactics executed over twelve years of orchestration and field execution expertise. It has driven demonstrated impact, including:

• 36% NBRx lift demonstrated across clients
• 19% sales performance increase by users following a competitor launch
• 20 minutes per day saved per rep in manual planning and logging

Aktana has made significant platform enhancements over the past 24 months. These include AI-powered communications planning, automated tactic optimization, and live strategic visibility to improve HCP journey design and execution. This sophisticated tech will now be boosted by white-glove partnership from a team that’s earned 100% client renewals.

The Canaccord Genuity team previously advised PharmaForceIQ on its significant investment from Eir Partners in September 2024.